Former Life Technologies executive Paul Grossman has joined Telegraph Hill Partners as a venture partner. Grossman previously was head of global strategy and corporate development at Life Tech, and he also held the same position at Invitrogen. Before he joined Invitrogen, Grossman held various leadership roles at Applied Biosystems, including as a research scientist and patent attorney, VP of intellectual property, and VP of strategy and business development.
IncellDx has hired healthcare industry veteran Christine Meda as its chief business officer. In this role, she will be in charge of partnering with drug developers to drive adoption of IncellDx's Cellular Multiplexing technology, which gauges proteomic and genomic markers in a single assay.
Previously, Meda was president of Response Genetics and VP of women's health at Roche Molecular Diagnostics, and director of scientific affairs at Schering AG.